Ondine Biomedical Gross Profit vs. Market Capitalization
| OBI Stock | 7.75 0.25 3.12% |
Gross Profit | First Reported 2006-06-30 | Previous Quarter 174.1 K | Current Value 258.9 K | Quarterly Volatility 158.7 K |
For Ondine Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ondine Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ondine Biomedical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ondine Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ondine Biomedical over time as well as its relative position and ranking within its peers.
Ondine |
Ondine Biomedical Market Capitalization vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ondine Biomedical's current stock value. Our valuation model uses many indicators to compare Ondine Biomedical value to that of its competitors to determine the firm's financial worth. Ondine Biomedical is considered to be number one stock in gross profit category among its peers. It also is considered to be number one stock in market capitalization category among its peers creating about 26.34 of Market Capitalization per Gross Profit. At present, Ondine Biomedical's Gross Profit is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ondine Biomedical's earnings, one of the primary drivers of an investment's value.Ondine Market Capitalization vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Ondine Biomedical |
| = | 1.25 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Ondine Biomedical |
| = | 33.03 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Ondine Market Capitalization vs Competition
Ondine Biomedical is considered to be number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is now estimated at about 697.65 Billion. Ondine Biomedical adds roughly 33.03 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Ondine Biomedical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ondine Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ondine Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of Ondine Biomedical's change in net profit over the period of time. It can combine multiple indicators of Ondine Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.1 K | -1.1 K | |
| Operating Income | -14.8 M | -15.5 M | |
| Net Loss | -14.4 M | -15.1 M | |
| Income Tax Expense | 94 K | 89.3 K | |
| Income Before Tax | -14.4 M | -15.1 M | |
| Total Other Income Expense Net | 393 K | 412.6 K | |
| Interest Income | 242 K | 194.4 K | |
| Net Loss | -45.1 M | -42.8 M | |
| Net Interest Income | 204 K | 214.2 K | |
| Net Loss | -14.4 M | -15.1 M | |
| Change To Netincome | 1.3 M | 1.2 M |
Ondine Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ondine Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ondine Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ondine Biomedical's important profitability drivers and their relationship over time.
Use Ondine Biomedical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ondine Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ondine Biomedical will appreciate offsetting losses from the drop in the long position's value.Ondine Biomedical Pair Trading
Ondine Biomedical Pair Trading Analysis
The ability to find closely correlated positions to Ondine Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ondine Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ondine Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ondine Biomedical to buy it.
The correlation of Ondine Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ondine Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ondine Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ondine Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Ondine Biomedical position
In addition to having Ondine Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Beer and Liquor Thematic Idea Now
Beer and Liquor
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Beer and Liquor theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beer and Liquor Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Ondine Stock
To fully project Ondine Biomedical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ondine Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ondine Biomedical's income statement, its balance sheet, and the statement of cash flows.